Published in Elder Law Weekly, February 14th, 2007
This trend article about National University, Singapore, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: A report, "Celecoxib reduces microvessel density in patients treated with nasopharyngeal carcinoma and induces changes in gene expression," is newly published data in Annals of Oncology. According to recent research published in the journal Annals of Oncology, "Celecoxib is a selective cyclooxygenase-2 inhibitor with antitumor and antiangiogenic activity. We sought to determine pharmacodynamic change in tumors of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Elder Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.